Anavex Life Sciences Touts Oral Alzheimer's Drug Blarcamesine Data, Cash Runway at Healthcare Conference [Yahoo! Finance]
Anavex Life Sciences Corp. (AVXL)
NASDAQ:AMEX Investor Relations:
anavex.com/share-data
Company Research
Source: Yahoo! Finance
Anavex Life Sciences (NASDAQ:AVXL) CEO Christopher Missling presented an update on the company's central nervous system pipeline at the firm's 46th Annual Healthcare Conference, highlighting late-stage data for its oral Alzheimer's candidate blarcamesine, upcoming regulatory and clinical milestones, and the company's cash position and intellectual property runway. Focus on oral, personalized CNS therapies Missling said Anavex is focused on developing “convenient oral personalized treatments” for central nervous system disorders, describing CNS as one of the largest areas of unmet need. He emphasized the company's goal of improving patient outcomes with an orally administered approach that can be used at home, which he said is important for both patients and caregivers. ? Defense Stocks Are Soaring—AeroVironment's Earnings Could Close the Gap He also underscored the growing burden of dementia and Alzheimer's disease, citing aging as a key risk factor and noting expectations fo
Show less
Read more
Impact Snapshot
Event Time:
AVXL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AVXL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AVXL alerts
High impacting Anavex Life Sciences Corp. news events
Weekly update
A roundup of the hottest topics
AVXL
News
- Anavex Life Sciences to Present at the Citizens Life Sciences ConferenceGlobeNewswire
- Anavex Life Sciences to Present at the 46th TD Cowen Annual Health Care Conference [Yahoo! Finance]Yahoo! Finance
- Anavex Life Sciences to Present at the 46th TD Cowen Annual Health Care ConferenceGlobeNewswire
- Anavex Life Sciences Appoints Seasoned Healthcare Leader to Board of DirectorsGlobeNewswire
- Anavex Life Sciences (NASDAQ:AVXL) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.MarketBeat
AVXL
Earnings
- 2/9/26 - Beat
AVXL
Sec Filings
- 2/25/26 - Form 8-K
- 2/9/26 - Form 10-Q
- 2/9/26 - Form 8-K
- AVXL's page on the SEC website